SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193805-21-001421
Filing Date
2021-10-06
Accepted
2021-10-06 09:52:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D e620994_sc13d-enzo.htm SC 13D 131762
2 GROUP AGREEMENT, DATED SEPTEMBER 29, 2021 e620994_ex99-1.htm EX-99.1 14455
3 POWER OF ATTORNEY e620994_ex99-2.htm EX-99.2 8299
  Complete submission text file 0001193805-21-001421.txt   155765
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13D | Act: 34 | File No.: 005-32878 | Film No.: 211308989
SIC: 8071 Services-Medical Laboratories

Mailing Address 1177 WEST LOOP SOUTH SUITE 1625 HOUSTON TX 77027
Business Address
Radoff Bradley Louis (Filed by) CIK: 0001380585 (see all company filings)

Type: SC 13D